PNC Financial Services Group
CYTK icon

PNC Financial Services Group’s Cytokinetics CYTK Stock Holding History

PNC Financial Services Group’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$844K Buy
9,910
+1,333
+16% +$95.7K ﹤0.01% 1484
2026
Q1 		$565K Buy
8,577
+53
+0.6% +$3.37K ﹤0.01% 1593
2025
Q4 		$542K Buy
8,524
+2,475
+41% +$154K ﹤0.01% 1594
2025
Q3 		$332K Buy
6,049
+1,343
+29% +$55.3K ﹤0.01% 1933
2025
Q2 		$155K Sell
4,706
-5,445
-54% -$189K ﹤0.01% 2383
2025
Q1 		$408K Buy
10,151
+1,885
+23% +$86.6K ﹤0.01% 1666
2024
Q4 		$389K Buy
8,266
+242
+3% +$12.6K ﹤0.01% 1719
2024
Q3 		$424K Buy
8,024
+1,441
+22% +$80.3K ﹤0.01% 1663
2024
Q2 		$357K Sell
6,583
-314
-5% -$19K ﹤0.01% 1734
2024
Q1 		$484K Buy
6,897
+41
+0.6% +$3.17K ﹤0.01% 1558
2023
Q4 		$572K Sell
6,856
-517
-7% -$18.7K ﹤0.01% 1441
2023
Q3 		$217K Buy
7,373
+340
+5% +$11.3K ﹤0.01% 2063
2023
Q2 		$229K Buy
7,033
+167
+2% +$6.18K ﹤0.01% 2106
2023
Q1 		$242K Buy
6,866
+30
+0.4% +$1.22K ﹤0.01% 2028
2022
Q4 		$313K Sell
6,836
-44
-0.6% -$1.89K ﹤0.01% 1830
2022
Q3 		$334K Buy
6,880
+360
+6% +$17.3K ﹤0.01% 1760
2022
Q2 		$257K Buy
6,520
+66
+1% +$2.66K ﹤0.01% 1973
2022
Q1 		$236K Buy
6,454
+372
+6% +$13.2K ﹤0.01% 2147
2021
Q4 		$276K Sell
6,082
-15
-0.2% -$579 ﹤0.01% 2057
2021
Q3 		$217K Buy
6,097
+1,131
+23% +$33.3K ﹤0.01% 2145
2021
Q2 		$98K Buy
4,966
+49
+1% +$1.15K ﹤0.01% 2667
2021
Q1 		$115K Buy
4,917
+681
+16% +$14.5K ﹤0.01% 2491
2020
Q4 		$89K Buy
4,236
+230
+6% +$4.2K ﹤0.01% 2564
2020
Q3 		$87K Buy
4,006
+13
+0.3% +$304 ﹤0.01% 2405
2020
Q2 		$93K Sell
3,993
-1
-0% -$19 ﹤0.01% 2378
2020
Q1 		$48K Buy
3,994
+126
+3% +$1.61K ﹤0.01% 2656
2019
Q4 		$41K Buy
3,868
+337
+10% +$3.46K ﹤0.01% 3002
2019
Q3 		$40K Sell
3,531
-3,862
-52% -$48.5K ﹤0.01% 3025
2019
Q2 		$84K Buy
7,393
+692
+10% +$6.67K ﹤0.01% 2638
2019
Q1 		$54K Sell
6,701
-790
-11% -$5.81K ﹤0.01% 2901
2018
Q4 		$48K Buy
7,491
+643
+9% +$4.72K ﹤0.01% 2888
2018
Q3 		$68K Buy
6,848
+152
+2% +$1.22K ﹤0.01% 2818
2018
Q2 		$56K Buy
6,696
+519
+8% +$4.32K ﹤0.01% 2907
2018
Q1 		$44K Buy
6,177
+1,108
+22% +$9.5K ﹤0.01% 3041
2017
Q4 		$41K Sell
5,069
-1,137
-18% -$12.9K ﹤0.01% 3047
2017
Q3 		$90K Sell
6,206
-78,303
-93% -$1.07M ﹤0.01% 2578
2017
Q2 		$1.02M Buy
84,509
+688
+0.8% +$9.56K ﹤0.01% 1276
2017
Q1 		$1.08M Sell
83,821
-85,395
-50% -$998K ﹤0.01% 1257
2016
Q4 		$2.06M Sell
169,216
-4,578
-3% -$48.6K ﹤0.01% 984
2016
Q3 		$1.6M Sell
173,794
-47,728
-22% -$498K ﹤0.01% 1078
2016
Q2 		$2.1M Buy
221,522
+215,689
+3,698% +$1.77M ﹤0.01% 917
2016
Q1 		$42K Hold
5,833
– – ﹤0.01% 2904
2015
Q4 		$61K Sell
5,833
-2,500
-30% -$24.5K ﹤0.01% 2730
2015
Q3 		$56K Buy
8,333
+4,500
+117% +$30.7K ﹤0.01% 2822
2015
Q2 		$26K Buy
3,833
+1,000
+35% +$6.56K ﹤0.01% 3374
2015
Q1 		$20K Buy
2,833
+2,000
+240% +$14.9K ﹤0.01% 3504
2014
Q4 		$7K Hold
833
– – ﹤0.01% 3453
2014
Q3 		$3K Hold
833
– – ﹤0.01% 3574
2014
Q2 		$4K Hold
833
– – ﹤0.01% 3350
2014
Q1 		$8K Hold
833
– – ﹤0.01% 3121
2013
Q4 		$5K Sell
833
-166
-17% -$1.09K ﹤0.01% 3129
2013
Q3 		$8K Buy
+999
New +$10.7K ﹤0.01% 3313

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $1.83B AUM 331.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PNC Financial Services Group's CYTK Position: Q2 2026 in Review

PNC Financial Services Group increased its Cytokinetics (CYTK) stake by 16% in Q2 2026, buying an estimated $95.7K and bringing the position to 9,910 shares worth $844K. The position accounts for ﹤0.01% of the portfolio, ranked #1484.

PNC Financial Services Group first reported a position in CYTK in Q3 2013 and has held it in 52 quarters since. The position peaked at $2.1M in Q2 2016. 196 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • PNC Financial Services Group held 9,910 shares of Cytokinetics worth $844K as of Q2 2026.
  • PNC Financial Services Group bought 1,333 Cytokinetics shares in Q2 2026, an estimated $95.7K.
  • Cytokinetics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1484 holding.
  • PNC Financial Services Group first reported a position in Cytokinetics in Q3 2013 and has held it in 52 quarters since.
  • PNC Financial Services Group's Cytokinetics position peaked at $2.1M in Q2 2016.
  • 196 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.